510(k) Summary of Safety and Effectiveness
August 31, 2020 Medtronic Minimed, Inc. Nicole Birch Senior Regulatory Affairs Specialist 18000 Devonshire Street Northridge, CA
Premarket Notification [510(k)]
Optimizing a Hybrid Closed Loop System in Type 1 Diabetes: A Case Report | SpringerLink
SSED Template
Management of diabetes and hyperglycaemia in the hospital - The Lancet Diabetes & Endocrinology
Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice
SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED)
Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
Summary of Safety and Effectivness (SSED)Template
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials | NEJM
Frontiers | Advancing Regulatory Science With Computational Modeling for Medical Devices at the FDA's Office of Science and Engineering Laboratories
Continuous Glucose Monitoring Overview: Features and Evidence
Continuous Glucose Monitor (CGM)
A Hybrid Closed-Loop Insulin Delivery System for the Treatment of Type 1 Diabetes - CADTH Issues in Emerging Health Technologies - NCBI Bookshelf
Flash Glucose Monitoring: A Patient's and Clinician's Caveats and Concerns - Endocrine Practice
CP.PHAR.534 Insulin Delivery Systems (V-Go, Omnipod, InPen)
Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control - Endotext - NCBI Bookshelf
Guardian™ Sensor 3 for the MiniMed™ 670G/630G system (5/box) | Diabetes Shop
0070 Diabetes Tests- Programs and Supplies (1)
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
MiniMed 770G System - P160017/S076 | FDA
1.01.30 Artificial Pancreas Device Systems
Optimizing a Hybrid Closed Loop System in Type 1 Diabetes: A Case Report | SpringerLink
